Icon

FARESTON (nda020497)- (EQ 60MG BASE)

TOREMIFENE CITRATE KYOWA KIRIN
EQ 60MG BASE
No No
2009-Sep-29 Expired
None None
None No
FARESTON® is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in postmenopausal women with estrogen-receptor positive or unknown tumors.
2 0 2
Total Other Developers 1
Drugs with Suitability No
EQ 60MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ****** *** *********** ******** ******** ****, *** ********* ****, *********, , ******* (***) ***
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.